Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CCR6 | P51684 | 1/20 | 0.30 |
| ▸ | KDM4A | O75164 | 1/20 | 0.30 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2587917 | 0.90 | KDM4E (0.35) | PKML3MBTL1MAPTSMN1; SMN2KDM4E | |
| SCHEMBL341039 | 0.80 | PKM (0.53) | PKML3MBTL1MAPTSMN1; SMN2KDM4E | |
| SCHEMBL29514516 | 0.80 | PKM (0.53) | PKML3MBTL1MAPTSMN1; SMN2KDM4E | |
| SCHEMBL9131865 | 0.79 | PKM (0.53) | PKML3MBTL1MAPTSMN1; SMN2KDM4E | |
| SCHEMBL15226760 | 0.78 | TSHR (0.36) | KDM4ETDP1ALOX12CYP3A4 | |
| SCHEMBL600529 | 0.76 | KDM4E (0.47) | PKML3MBTL1MAPTSMN1; SMN2KDM4E | |
| SCHEMBL3717116 | 0.74 | PKM (0.42) | PKML3MBTL1MAPTSMN1; SMN2KDM4E | |
| SCHEMBL9953942 | 0.74 | KDM4E (0.34) | PKML3MBTL1MAPTSMN1; SMN2KDM4E | |
| SCHEMBL600770 | 0.73 | KDM4E (0.44) | PKML3MBTL1MAPTSMN1; SMN2KDM4E | |
| SCHEMBL14969485 | 0.73 | KDM4E (0.50) | PKML3MBTL1MAPTSMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2421371-A1 | USE OF PROPINEB AS BIRD REPELLENT | Bayer CropScience AG (DE) | 2012-02-29 | — | — | EP | disclosed |
| WO-2011107443-A1 | USE OF PROPINEB FOR PHYSIOLOGICAL CURATIVE TREATMENT UNDER ZINC DEFICIENCY | BAYER CROPSCIENCE AG (DE) | 2011-09-09 | — | — | WO | disclosed |
| US-20110218107-A1 | Use of Propineb for Physiological Curative Treatment Under Zinc Deficiency | BAYER CROPSCIENCE AG (DE) | 2011-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110218107-A1 | Use of Propineb for Physiological Curative Treatment Under Zinc Deficiency | PLPBP, ZFR, CTRB1 | PKM 686/4885L3MBTL1 197/4885MAPT 4224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.